1. Home
  2. PBM vs AIMD Comparison

PBM vs AIMD Comparison

Compare PBM & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBM
  • AIMD
  • Stock Information
  • Founded
  • PBM 1994
  • AIMD 1984
  • Country
  • PBM Canada
  • AIMD United States
  • Employees
  • PBM N/A
  • AIMD N/A
  • Industry
  • PBM
  • AIMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • PBM
  • AIMD Health Care
  • Exchange
  • PBM NYSE
  • AIMD Nasdaq
  • Market Cap
  • PBM 7.5M
  • AIMD 8.5M
  • IPO Year
  • PBM N/A
  • AIMD N/A
  • Fundamental
  • Price
  • PBM $1.37
  • AIMD $0.62
  • Analyst Decision
  • PBM
  • AIMD
  • Analyst Count
  • PBM 0
  • AIMD 0
  • Target Price
  • PBM N/A
  • AIMD N/A
  • AVG Volume (30 Days)
  • PBM 532.1K
  • AIMD 1.3M
  • Earning Date
  • PBM 02-02-2025
  • AIMD 03-07-2025
  • Dividend Yield
  • PBM N/A
  • AIMD N/A
  • EPS Growth
  • PBM N/A
  • AIMD N/A
  • EPS
  • PBM N/A
  • AIMD N/A
  • Revenue
  • PBM N/A
  • AIMD $40,633.00
  • Revenue This Year
  • PBM N/A
  • AIMD N/A
  • Revenue Next Year
  • PBM N/A
  • AIMD N/A
  • P/E Ratio
  • PBM N/A
  • AIMD N/A
  • Revenue Growth
  • PBM N/A
  • AIMD N/A
  • 52 Week Low
  • PBM $1.21
  • AIMD $0.40
  • 52 Week High
  • PBM $323.25
  • AIMD $3.10
  • Technical
  • Relative Strength Index (RSI)
  • PBM 37.76
  • AIMD 48.56
  • Support Level
  • PBM $1.21
  • AIMD $0.57
  • Resistance Level
  • PBM $1.59
  • AIMD $0.87
  • Average True Range (ATR)
  • PBM 0.24
  • AIMD 0.09
  • MACD
  • PBM 0.03
  • AIMD -0.02
  • Stochastic Oscillator
  • PBM 17.53
  • AIMD 17.45

About PBM PSYENCE BIOMEDICAL LTD

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

Share on Social Networks: